{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:20:14Z","timestamp":1787494814092,"version":"build-2736575974"},"reference-count":176,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-025-03870-2","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T04:42:43Z","timestamp":1764909763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The blood\u2013retinal barrier in ocular pathologies: an updated narrative review"],"prefix":"10.1007","volume":"46","author":[{"given":"Zhongci","family":"Hang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwu","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"issue":"1","key":"3870_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12929-024-01036-3","volume":"31","author":"M Beatriz","year":"2024","unstructured":"Beatriz M, Maria P, Ant\u00f3nio Francisco A et al (2024) Contribution of extracellular vesicles for the pathogenesis of retinal diseases: shedding light on blood\u2013retinal barrier dysfunction. J Biomed Sci 31(1):48. https:\/\/doi.org\/10.1186\/s12929-024-01036-3","journal-title":"J Biomed Sci"},{"issue":"4","key":"3870_CR2","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/febs.16330","volume":"290","author":"OL Fionn","year":"2021","unstructured":"Fionn OL, Matthew C (2021) The blood-retina barrier in health and disease. FEBS J. 290(4):878\u2013891. https:\/\/doi.org\/10.1111\/febs.16330","journal-title":"FEBS J."},{"issue":"5","key":"3870_CR3","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3390\/life13051098","volume":"13","author":"AB Tyler","year":"2023","unstructured":"Tyler AB, Sophie JB (2023) Update on the management of diabetic retinopathy: anti-VEGF agents for the prevention of complications and progression of nonproliferative and proliferative retinopathy. Life (Basel) 13(5):1098. https:\/\/doi.org\/10.3390\/life13051098","journal-title":"Life (Basel)"},{"issue":"21","key":"3870_CR4","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.3390\/cells11213362","volume":"11","author":"Z Jingfa","year":"2022","unstructured":"Jingfa Z, Jingxiang Z, Chaoyang Z et al (2022) Diabetic macular edema: current understanding, molecular mechanisms and therapeutic implications. Cells. 11(21):3362. https:\/\/doi.org\/10.3390\/cells11213362","journal-title":"Cells."},{"key":"3870_CR5","doi-asserted-by":"publisher","DOI":"10.5301\/ejo.2010.6049","author":"C-V Jos\u00e9","year":"2011","unstructured":"Jos\u00e9 C-V, Rui B, Concei\u00e7\u00e3o L (2011) Blood\u2013retinal barrier. Eur J Ophthalmol. https:\/\/doi.org\/10.5301\/ejo.2010.6049","journal-title":"Eur J Ophthalmol"},{"issue":"8","key":"3870_CR6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1136\/bjo.50.8.441","volume":"50","author":"JG Cunha-Vaz","year":"1966","unstructured":"Cunha-Vaz JG, Shakib M, Ashton N (1966) Studies on the permeability of the blood\u2013retinal barrier. I. On the existence, development, and site of a blood\u2013retinal barrier. Br J Ophthalmol 50(8):441. https:\/\/doi.org\/10.1136\/bjo.50.8.441","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"3870_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00417-016-3548-y","volume":"255","author":"WG Thomas","year":"2016","unstructured":"Thomas WG, Jose RD (2016) The neurovascular unit and the pathophysiologic basis of diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 255(1):1\u20136. https:\/\/doi.org\/10.1007\/s00417-016-3548-y","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"3870_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40662-021-00239-1","volume":"8","author":"N Shen","year":"2021","unstructured":"Shen N, Amy CYL, Yajing M et al (2021) Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets. Eye Vis (Lond) 8(1):15. https:\/\/doi.org\/10.1186\/s40662-021-00239-1","journal-title":"Eye Vis (Lond)"},{"key":"3870_CR9","doi-asserted-by":"publisher","first-page":"1048634","DOI":"10.3389\/fnmol.2022.1048634","volume":"15","author":"W Yan","year":"2022","unstructured":"Yan W, Xiongyi Y, Qiumo L et al (2022) Single-cell RNA sequencing reveals the M\u00fcller subtypes and inner blood\u2013retinal barrier regulatory network in early diabetic retinopathy. Front Mol Neurosci 15:1048634. https:\/\/doi.org\/10.3389\/fnmol.2022.1048634","journal-title":"Front Mol Neurosci"},{"issue":"5","key":"3870_CR10","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.visres.2006.11.017","volume":"47","author":"G David","year":"2007","unstructured":"David G, Jean-Armand C, Michel P et al (2007) Microglial changes occur without neural cell death in diabetic retinopathy. Vision Res 47(5):612\u2013623. https:\/\/doi.org\/10.1016\/j.visres.2006.11.017","journal-title":"Vision Res"},{"key":"3870_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.preteyeres.2013.02.001","volume":"34","author":"K Ingeborg","year":"2013","unstructured":"Ingeborg K, Cornelis JFVN, Reinier OS (2013) Molecular basis of the inner blood\u2013retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Prog Retin Eye Res 34:19\u201348. https:\/\/doi.org\/10.1016\/j.preteyeres.2013.02.001","journal-title":"Prog Retin Eye Res"},{"key":"3870_CR12","doi-asserted-by":"publisher","first-page":"100803","DOI":"10.1016\/j.preteyeres.2019.100803","volume":"76","author":"AF Mark","year":"2019","unstructured":"Mark AF, Lucian VDP, Ron AA et al (2019) Interactions of the choroid, Bruch\u2019s membrane, retinal pigment epithelium, and neurosensory retina collaborate to form the outer blood-retinal-barrier. Prog Retin Eye Res 76:100803. https:\/\/doi.org\/10.1016\/j.preteyeres.2019.100803","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"3870_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3390\/ijms21010211","volume":"21","author":"N Aisling","year":"2020","unstructured":"Aisling N, Alan H, Natalie H et al (2020) Tight junctions of the outer blood retina barrier. Int J Mol Sci 21(1):211. https:\/\/doi.org\/10.3390\/ijms21010211","journal-title":"Int J Mol Sci"},{"key":"3870_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/978-1-4939-7720-8_4","volume-title":"mouse retinal phenotyping: methods and protocols","author":"RA Hazim","year":"2018","unstructured":"Hazim RA, Williams DS (2018) Cell culture analysis of the phagocytosis of photoreceptor outer segments by primary mouse RPE cells. mouse retinal phenotyping: methods and protocols. Springer, New York, pp 63\u201371"},{"key":"3870_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.preteyeres.2017.03.002","volume":"60","author":"D Sayantan","year":"2017","unstructured":"Sayantan D, Marisol C, Katayoon E et al (2017) The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD. Prog Retin Eye Res 60:201\u2013218. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.03.002","journal-title":"Prog Retin Eye Res"},{"issue":"45","key":"3870_CR16","doi-asserted-by":"publisher","first-page":"2404067","DOI":"10.1002\/advs.202404067","volume":"11","author":"Y Song","year":"2024","unstructured":"Song Y, Fan Y, Mulin Y et al (2024) CYLD maintains retinal homeostasis by deubiquitinating ENKD1 and promoting the phagocytosis of photoreceptor outer segments. Adv Sci (Weinh) 11(45):2404067. https:\/\/doi.org\/10.1002\/advs.202404067","journal-title":"Adv Sci (Weinh)"},{"issue":"5","key":"3870_CR17","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/s0002-9440(10)61231-x","volume":"167","author":"GM Alexander","year":"2005","unstructured":"Alexander GM, Jie F, Yoshihito Y et al (2005) Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. Am J Pathol 167(5):1451\u20131459. https:\/\/doi.org\/10.1016\/s0002-9440(10)61231-x","journal-title":"Am J Pathol"},{"key":"3870_CR18","doi-asserted-by":"publisher","first-page":"190724","DOI":"10.1155\/2010\/190724","volume":"2010","author":"S Rafael","year":"2010","unstructured":"Rafael S, Marta V, L\u00eddia C et al (2010) The retinal pigment epithelium: something more than a constituent of the blood\u2013retinal barrier\u2013implications for the pathogenesis of diabetic retinopathy. J Biomed Biotechnol 2010:190724. https:\/\/doi.org\/10.1155\/2010\/190724","journal-title":"J Biomed Biotechnol"},{"key":"3870_CR19","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00021.2004","author":"S Olaf","year":"2005","unstructured":"Olaf S (2005) The retinal pigment epithelium in visual function. Physiol Rev. https:\/\/doi.org\/10.1152\/physrev.00021.2004","journal-title":"Physiol Rev"},{"issue":"1","key":"3870_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.1998.tb10102.x","volume":"857","author":"AD Marmorstein","year":"1998","unstructured":"Marmorstein AD et al (1998) Morphogenesis of the retinal pigment epithelium: toward understanding retinal degenerative diseases. Ann N Y Acad Sci 857(1):1\u201312. https:\/\/doi.org\/10.1111\/j.1749-6632.1998.tb10102.x","journal-title":"Ann N Y Acad Sci"},{"key":"3870_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fncel.2016.00020","volume":"10","author":"T Andrea","year":"2016","unstructured":"Andrea T, Simona L, Falk S et al (2016) Brain and retinal pericytes: origin function and role. Front Cell Neurosci 10:20. https:\/\/doi.org\/10.3389\/fncel.2016.00020","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"3870_CR22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.devcel.2011.07.001","volume":"21","author":"A Annika","year":"2011","unstructured":"Annika A, Guillem G, Christer B (2011) Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 21(2):193\u2013215. https:\/\/doi.org\/10.1016\/j.devcel.2011.07.001","journal-title":"Dev Cell"},{"issue":"1672","key":"3870_CR23","doi-asserted-by":"publisher","first-page":"20140195","DOI":"10.1098\/rstb.2014.0195","volume":"370","author":"AN Eric","year":"2015","unstructured":"Eric AN (2015) Glial cell regulation of neuronal activity and blood flow in the retina by release of gliotransmitters. Philos Trans R Soc Lond B Biol Sci 370(1672):20140195. https:\/\/doi.org\/10.1098\/rstb.2014.0195","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"5","key":"3870_CR24","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.3390\/ijms21051636","volume":"21","author":"GF Claudia","year":"2020","unstructured":"Claudia GF, Annamaria F, Giuseppe C et al (2020) A New human blood\u2013retinal barrier model based on endothelial cells, pericytes, and astrocytes. Int J Mol Sci 21(5):1636. https:\/\/doi.org\/10.3390\/ijms21051636","journal-title":"Int J Mol Sci"},{"key":"3870_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.06.003","volume":"51","author":"E Vecino","year":"2016","unstructured":"Vecino E, Rodriguez FD, Ruzafa N, Pereiro X, Sharma SC (2016) Glia\u2013neuron interactions in the mammalian retina. Prog Retin Eye Res 51:1\u201340. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.06.003","journal-title":"Prog Retin Eye Res"},{"key":"3870_CR26","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.3389\/fimmu.2018.02576","volume":"9","author":"C Maureen","year":"2018","unstructured":"Maureen C, William A Jr, Microglia P (2018) Immune regulators of neurodevelopment. Front Immunol 9:2576. https:\/\/doi.org\/10.3389\/fimmu.2018.02576","journal-title":"Front Immunol"},{"key":"3870_CR27","doi-asserted-by":"publisher","first-page":"1100254","DOI":"10.3389\/fnmol.2023.1100254","volume":"16","author":"F Xuefei","year":"2023","unstructured":"Xuefei F, Shuyu F, Huan Q et al (2023) Microglia: The breakthrough to treat neovascularization and repair blood\u2013retinal barrier in retinopathy. Front Mol Neurosci 16:1100254. https:\/\/doi.org\/10.3389\/fnmol.2023.1100254","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"3870_CR28","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1152\/physrev.00035.2003","volume":"84","author":"B Gianfranco","year":"2004","unstructured":"Gianfranco B, Elisabetta D (2004) Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 84(3):869\u2013901. https:\/\/doi.org\/10.1152\/physrev.00035.2003","journal-title":"Physiol Rev"},{"issue":"2","key":"3870_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/08820530902800355","volume":"24","author":"SS Paolo","year":"2009","unstructured":"Paolo SS, Jennifer KS, Lloyd Paul A (2009) Role of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy. Semin Ophthalmol 24(2):93\u201399. https:\/\/doi.org\/10.1080\/08820530902800355","journal-title":"Semin Ophthalmol"},{"issue":"27","key":"3870_CR30","doi-asserted-by":"publisher","first-page":"20520","DOI":"10.1074\/jbc.M905251199","volume":"275","author":"G Bazzoni","year":"2000","unstructured":"Bazzoni G, Mart\u0131nez-Estrada OM, Orsenigo F, Cordenonsi M, Citi S, Dejana E (2000) Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. J Biol Chem 275(27):20520\u201320526. https:\/\/doi.org\/10.1074\/jbc.M905251199","journal-title":"J Biol Chem"},{"issue":"5","key":"3870_CR31","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.preteyeres.2011.06.002","volume":"30","author":"JR Lawrence","year":"2011","unstructured":"Lawrence JR, Shaomin P, Yan L et al (2011) Integration of tight junctions and claudins with the barrier functions of the retinal pigment epithelium. Prog Retin Eye Res 30(5):296\u2013323. https:\/\/doi.org\/10.1016\/j.preteyeres.2011.06.002","journal-title":"Prog Retin Eye Res"},{"issue":"12","key":"3870_CR32","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1091\/mbc.11.12.4131","volume":"11","author":"M Saitou","year":"2000","unstructured":"Saitou M, Furuse M, Sasaki H, Schulzke JD, Fromm M, Takano H, Tsukita S (2000) Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 11(12):4131\u20134142. https:\/\/doi.org\/10.1091\/mbc.11.12.4131","journal-title":"Mol Biol Cell"},{"key":"3870_CR33","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00038.2002","author":"RC Oscar","year":"2002","unstructured":"Oscar RC, Christina MVI, Heather JM et al (2002) Claudins create charge-selective channels in the paracellular pathway between epithelial cells. Am J Physiol Cell Physiol. https:\/\/doi.org\/10.1152\/ajpcell.00038.2002","journal-title":"Am J Physiol Cell Physiol"},{"key":"3870_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1146\/annurev.cellbio.22.010305.104219","volume":"22","author":"S Kunyoo","year":"2006","unstructured":"Kunyoo S, Vanessa CF, Ben M (2006) Tight junctions and cell polarity. Annu Rev Cell Dev Biol 22:207\u2013235. https:\/\/doi.org\/10.1146\/annurev.cellbio.22.010305.104219","journal-title":"Annu Rev Cell Dev Biol"},{"key":"3870_CR35","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1146\/annurev.physiol.68.040104.131404","volume":"68","author":"MVI Christina","year":"2006","unstructured":"Christina MVI, James MA (2006) Claudins and epithelial paracellular transport. Annu Rev Physiol 68:403\u2013429. https:\/\/doi.org\/10.1146\/annurev.physiol.68.040104.131404","journal-title":"Annu Rev Physiol"},{"issue":"10","key":"3870_CR36","doi-asserted-by":"publisher","first-page":"7556","DOI":"10.1167\/iovs.11-7185","volume":"52","author":"L Yan","year":"2011","unstructured":"Yan L, Wei X, Xiaobo Z et al (2011) Differential expression of claudins in retinas during normal development and the angiogenesis of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 52(10):7556\u20137564. https:\/\/doi.org\/10.1167\/iovs.11-7185","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3870_CR37","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s42003-019-0355-0","volume":"2","author":"W Shao-Bin","year":"2019","unstructured":"Shao-Bin W, Tao X, Shaomin P et al (2019) Disease-associated mutations of claudin-19 disrupt retinal neurogenesis and visual function. Commun Biol 2:113. https:\/\/doi.org\/10.1038\/s42003-019-0355-0","journal-title":"Commun Biol"},{"issue":"6","key":"3870_CR38","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1167\/iovs.09-4162","volume":"51","author":"P Shaomin","year":"2010","unstructured":"Shaomin P, Ron AA, Lawrence JR (2010) Minimal effects of VEGF and anti-VEGF drugs on the permeability or selectivity of RPE tight junctions. Invest Ophthalmol Vis Sci 51(6):3216\u20133225. https:\/\/doi.org\/10.1167\/iovs.09-4162","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"3870_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.yexcr.2017.03.061","volume":"358","author":"KC Hannah","year":"2017","unstructured":"Hannah KC, Jessica LM, Kris AD (2017) Interplay between tight junctions & adherens junctions. Exp Cell Res 358(1):39\u201344. https:\/\/doi.org\/10.1016\/j.yexcr.2017.03.061","journal-title":"Exp Cell Res"},{"key":"3870_CR40","doi-asserted-by":"publisher","first-page":"101245","DOI":"10.1016\/j.preteyeres.2024.101245","volume":"99","author":"T-N Oren","year":"2024","unstructured":"Oren T-N, Rachael N, John G et al (2024) Mechanisms of blood\u2013retinal barrier disruption related to intraocular inflammation and malignancy. Prog Retin Eye Res 99:101245. https:\/\/doi.org\/10.1016\/j.preteyeres.2024.101245","journal-title":"Prog Retin Eye Res"},{"key":"3870_CR41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.preteyeres.2018.10.003","volume":"69","author":"C Mei","year":"2018","unstructured":"Mei C, Chang L, Jiawu Z et al (2018) Immune regulation in the aging retina. Prog Retin Eye Res 69:159\u2013172. https:\/\/doi.org\/10.1016\/j.preteyeres.2018.10.003","journal-title":"Prog Retin Eye Res"},{"issue":"21","key":"3870_CR42","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1097\/cm9.0000000000001015","volume":"133","author":"Y Xue","year":"2020","unstructured":"Xue Y, Xiao-Wei Y, Dan-Dan Z et al (2020) Blood\u2013retinal barrier as a converging pivot in understanding the initiation and development of retinal diseases. Chin Med J (Engl) 133(21):2586\u20132594. https:\/\/doi.org\/10.1097\/cm9.0000000000001015","journal-title":"Chin Med J (Engl)"},{"key":"3870_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.preteyeres.2013.02.001","volume":"34","author":"I Klaassen","year":"2013","unstructured":"Klaassen I, Van Noorden C, Schlingemann R (2013) Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Prog Retin Eye Res 34:19\u201348. https:\/\/doi.org\/10.1016\/j.preteyeres.2013.02.001","journal-title":"Prog Retin Eye Res"},{"key":"3870_CR44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.preteyeres.2018.10.003","volume":"69","author":"M Chen","year":"2019","unstructured":"Chen M, Luo C, Zhao J et al (2019) Immune regulation in the aging retina. Prog Retin Eye Res 69:159\u2013172. https:\/\/doi.org\/10.1016\/j.preteyeres.2018.10.003","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"3870_CR45","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.preteyeres.2009.06.001","volume":"28","author":"H Xu","year":"2009","unstructured":"Xu H, Chen M, Forrester J (2009) Para-inflammation in the aging retina. Prog Retin Eye Res 28(5):348\u2013368. https:\/\/doi.org\/10.1016\/j.preteyeres.2009.06.001","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"3870_CR46","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1113\/expphysiol.2006.036376","volume":"92","author":"RM Monica","year":"2007","unstructured":"Monica RM, Eric AN (2007) Signalling within the neurovascular unit in the mammalian retina. Exp Physiol 92(4):635\u2013640. https:\/\/doi.org\/10.1113\/expphysiol.2006.036376","journal-title":"Exp Physiol"},{"key":"3870_CR47","doi-asserted-by":"publisher","first-page":"108718","DOI":"10.1016\/j.exer.2021.108718","volume":"210","author":"S Licheng","year":"2021","unstructured":"Licheng S, Ruonan W, Guangyi H et al (2021) Single cell RNA sequencing (scRNA-Seq) deciphering pathological alterations in streptozotocin-induced diabetic retinas. Exp Eye Res 210:108718. https:\/\/doi.org\/10.1016\/j.exer.2021.108718","journal-title":"Exp Eye Res"},{"issue":"5","key":"3870_CR48","doi-asserted-by":"publisher","first-page":"e0154560","DOI":"10.1371\/journal.pone.0154560","volume":"11","author":"SC Phillip","year":"2016","unstructured":"Phillip SC, Brandt JW, Frederick CM et al (2016) Bloodstream-to-eye infections are facilitated by outer blood\u2013retinal barrier dysfunction. PLoS One 11(5):e0154560. https:\/\/doi.org\/10.1371\/journal.pone.0154560","journal-title":"PLoS One"},{"issue":"1","key":"3870_CR49","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s40478-020-01076-4","volume":"8","author":"S Haoshen","year":"2020","unstructured":"Haoshen S, Yosef K, Dieu-Trang F et al (2020) Retinal capillary degeneration and blood\u2013retinal barrier disruption in murine models of Alzheimer\u2019s disease. Acta Neuropathol Commun 8(1):202. https:\/\/doi.org\/10.1186\/s40478-020-01076-4","journal-title":"Acta Neuropathol Commun"},{"key":"3870_CR50","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000320006","volume":"46","author":"JS Martin","year":"2010","unstructured":"Martin JS, Albert JA, Reinier OS (2010) Mechanisms of ocular angiogenesis and its molecular mediators. Dev Ophthalmol 46:4\u201320. https:\/\/doi.org\/10.1159\/000320006","journal-title":"Dev Ophthalmol"},{"key":"3870_CR51","doi-asserted-by":"publisher","first-page":"105115","DOI":"10.1016\/j.phrs.2020.105115","volume":"161","author":"R Madhuri","year":"2020","unstructured":"Madhuri R, Priya S, Narayanan, Payaningal RS (2020) Regulation of blood\u2013retinal barrier cell-junctions in diabetic retinopathy. Pharmacol Res 161:105115. https:\/\/doi.org\/10.1016\/j.phrs.2020.105115","journal-title":"Pharmacol Res"},{"issue":"7","key":"3870_CR52","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3390\/biomedicines9070831","volume":"9","author":"MB Eimear","year":"2021","unstructured":"Eimear MB, Mar\u00eda L-S, Miao T et al (2021) IL-17A damages the blood\u2013retinal barrier through activating the Janus Kinase 1 pathway. Biomedicines 9(7):831. https:\/\/doi.org\/10.3390\/biomedicines9070831","journal-title":"Biomedicines"},{"issue":"1","key":"3870_CR53","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ophtha.2012.07.038","volume":"120","author":"WM Joan","year":"2012","unstructured":"Joan WM, Jennifer LC, Erich CS et al (2012) Vascular endothelial growth factor a in intraocular vascular disease. Ophthalmology 120(1):106\u2013114. https:\/\/doi.org\/10.1016\/j.ophtha.2012.07.038","journal-title":"Ophthalmology"},{"issue":"2","key":"3870_CR54","doi-asserted-by":"publisher","first-page":"112347","DOI":"10.1016\/j.yexcr.2020.112347","volume":"397","author":"A Lennikov","year":"2020","unstructured":"Lennikov A, Mukwaya A, Fan L et al (2020) Synergistic interactions of PlGF and VEGF contribute to blood\u2013retinal barrier breakdown through canonical NF\u03baB activation. Exp Cell Res 397(2):112347. https:\/\/doi.org\/10.1016\/j.yexcr.2020.112347","journal-title":"Exp Cell Res"},{"key":"3870_CR55","doi-asserted-by":"publisher","unstructured":"Antonetti D, Barber A, Khin S, et al. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes. 1998;47(12):1953\u20139. https:\/\/doi.org\/10.2337\/diabetes.47.12.1953","DOI":"10.2337\/diabetes.47.12.1953"},{"issue":"5","key":"3870_CR56","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1167\/iovs.02-0807","volume":"44","author":"S Ishida","year":"2003","unstructured":"Ishida S, Usui T, Yamashiro K et al (2003) VEGF164 is proinflammatory in the diabetic retina. Invest Ophthalmol Vis Sci 44(5):2155\u20132162. https:\/\/doi.org\/10.1167\/iovs.02-0807","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"3870_CR57","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2337\/db14-0016","volume":"64","author":"H Hu","year":"2014","unstructured":"Hu H, Jianbo H, Da\u2019Kuawn J et al (2014) Deletion of placental growth factor prevents diabetic retinopathy and is associated with Akt activation and HIF1\u03b1-VEGF pathway inhibition. Diabetes 64(1):200\u2013212. https:\/\/doi.org\/10.2337\/db14-0016","journal-title":"Diabetes"},{"issue":"11","key":"3870_CR58","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.2337\/db09-1606","volume":"59","author":"AA C\u00e9lia","year":"2010","unstructured":"C\u00e9lia AA, Cheng-Mao L, Steven FA et al (2010) TNF-\u03b1 signals through PKC\u03b6\/NF-\u03baB to alter the tight junction complex and increase retinal endothelial cell permeability. Diabetes 59(11):2872\u20132882. https:\/\/doi.org\/10.2337\/db09-1606","journal-title":"Diabetes"},{"key":"3870_CR59","doi-asserted-by":"publisher","first-page":"156407","DOI":"10.1016\/j.cyto.2023.156407","volume":"173","author":"BF Lisia","year":"2023","unstructured":"Lisia BF, Liam MA, Yuefang M et al (2023) Effects of tumor necrosis factor-\u03b1 and interleukin-1\u03b2 on human retinal endothelial cells. Cytokine 173:156407. https:\/\/doi.org\/10.1016\/j.cyto.2023.156407","journal-title":"Cytokine"},{"issue":"5","key":"3870_CR60","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/labinvest.3700251","volume":"85","author":"JG Stephen","year":"2005","unstructured":"Stephen JG, Gina M, Paul GM et al (2005) Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood\u2013retinal barrier. Lab Invest 85(5):597\u2013607. https:\/\/doi.org\/10.1038\/labinvest.3700251","journal-title":"Lab Invest"},{"issue":"2","key":"3870_CR61","doi-asserted-by":"publisher","first-page":"2302776","DOI":"10.1002\/advs.202302776","volume":"11","author":"K So-Yeon","year":"2023","unstructured":"So-Yeon K, Nam GuY, Jin Young I et al (2023) Targeting the mitochondrial chaperone TRAP1 alleviates vascular pathologies in ischemic retinopathy. Adv Sci (Weinh) 11(2):2302776. https:\/\/doi.org\/10.1002\/advs.202302776","journal-title":"Adv Sci (Weinh)"},{"issue":"4","key":"3870_CR62","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/s0014-4835(02)00332-9","volume":"76","author":"G Nisha","year":"2003","unstructured":"Nisha G, Kimberly EB, Ann HM (2003) Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. Exp Eye Res 76(4):463\u2013471. https:\/\/doi.org\/10.1016\/s0014-4835(02)00332-9","journal-title":"Exp Eye Res"},{"issue":"12","key":"3870_CR63","doi-asserted-by":"publisher","first-page":"e137317","DOI":"10.1172\/jci.insight.137317","volume":"5","author":"U-O Ayumi","year":"2020","unstructured":"Ayumi U-O, Yoshihiko U, Toshihide K et al (2020) Retinal microglia are critical for subretinal neovascular formation. JCI Insight 5(12):e137317. https:\/\/doi.org\/10.1172\/jci.insight.137317","journal-title":"JCI Insight"},{"issue":"1","key":"3870_CR64","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12974-018-1373-4","volume":"15","author":"K Despina","year":"2018","unstructured":"Despina K, Andreas E, Pascal E et al (2018) Colony-stimulating factor 1 receptor inhibition prevents disruption of the blood-retina barrier during chronic inflammation. J Neuroinflammation 15(1):340. https:\/\/doi.org\/10.1186\/s12974-018-1373-4","journal-title":"J Neuroinflammation"},{"issue":"45","key":"3870_CR65","doi-asserted-by":"publisher","first-page":"15715","DOI":"10.1523\/jneurosci.2841-12.2012","volume":"32","author":"S Weiyong","year":"2012","unstructured":"Weiyong S, Marcus F, Ling Z et al (2012) Conditional M\u00fcllercell ablation causes independent neuronal and vascular pathologies in a novel transgenic model. J Neurosci 32(45):15715\u201315727. https:\/\/doi.org\/10.1523\/jneurosci.2841-12.2012","journal-title":"J Neurosci"},{"issue":"35","key":"3870_CR66","doi-asserted-by":"publisher","first-page":"eaba7457","DOI":"10.1126\/sciadv.aba7457","volume":"6","author":"W Zhongxiao","year":"2020","unstructured":"Zhongxiao W, Chi-Hsiu L, Shuo H et al (2020) Wnt signaling activates MFSD2A to suppress vascular endothelial transcytosis and maintain blood\u2013retinal barrier. Sci Adv 6(35):eaba7457. https:\/\/doi.org\/10.1126\/sciadv.aba7457","journal-title":"Sci Adv"},{"key":"3870_CR67","doi-asserted-by":"publisher","first-page":"E006","DOI":"10.1017\/s0952523821000031","volume":"38","author":"L Xin","year":"2021","unstructured":"Xin L, Zi-Wei Y, Hui-Yao L et al (2021) Retinal microglia polarization in diabetic retinopathy. Vis Neurosci 38:E006. https:\/\/doi.org\/10.1017\/s0952523821000031","journal-title":"Vis Neurosci"},{"key":"3870_CR68","doi-asserted-by":"publisher","first-page":"564077","DOI":"10.3389\/fimmu.2020.564077","volume":"11","author":"K Urbanus Muthai","year":"2020","unstructured":"Urbanus Muthai K, Anne W, Thomas L (2020) Microglia and inflammatory responses in diabetic retinopathy. Front Immunol 11:564077. https:\/\/doi.org\/10.3389\/fimmu.2020.564077","journal-title":"Front Immunol"},{"key":"3870_CR69","doi-asserted-by":"publisher","unstructured":"Sigal M-G, Pippa L, Bracha T, et al. Response to the Letter-to-the Editor by Cohen et al. concerning our eNeurologicalSci article, Melamed-Gal, et al. Physicochemical, biological, functional and toxicological characterization of the European follow-on glatiramer acetate product as compared with Copaxone. eNeurologicalSci 2018;12:19\u201330. https:\/\/doi.org\/10.1016\/j.ensci.2018.05.006. eNeurologicalSci. 2018;13.https:\/\/doi.org\/10.1016\/j.ensci.2018.11.007","DOI":"10.1016\/j.ensci.2018.05.006"},{"key":"3870_CR70","doi-asserted-by":"publisher","first-page":"108490","DOI":"10.1016\/j.exer.2021.108490","volume":"205","author":"I Makoto","year":"2021","unstructured":"Makoto I, Heping X, Masaru T et al (2021) Microglia increase tight-junction permeability in coordination with M\u00fcller cells under hypoxic condition in an in vitro model of inner blood\u2013retinal barrier. Exp Eye Res 205:108490. https:\/\/doi.org\/10.1016\/j.exer.2021.108490","journal-title":"Exp Eye Res"},{"key":"3870_CR71","doi-asserted-by":"publisher","first-page":"2156273","DOI":"10.1155\/2016\/21562735","volume":"2016","author":"R-A Pedro","year":"2016","unstructured":"Pedro R-A, Marc B-B, Alicia P-R et al (2016) Diabetic macular edema pathophysiology: vasogenic versus inflammatory. J Diabetes Res 2016:2156273. https:\/\/doi.org\/10.1155\/2016\/21562735","journal-title":"J Diabetes Res"},{"issue":"5","key":"3870_CR72","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00417-006-0516-y","volume":"245","author":"R Andreas","year":"2007","unstructured":"Andreas R, Antje W, Thomas P et al (2007) M\u00fcller cells as players in retinal degeneration and edema. Graefes Arch Clin Exp Ophthalmol 245(5):627\u2013636. https:\/\/doi.org\/10.1007\/s00417-006-0516-y","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10386","key":"3870_CR73","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/s0140-6736(22)02609-5","volume":"401","author":"HG Robyn","year":"2023","unstructured":"Robyn HG, Thomas GC (2023) Age-related macular degeneration. Lancet 401(10386):1459\u20131472. https:\/\/doi.org\/10.1016\/s0140-6736(22)02609-5","journal-title":"Lancet"},{"issue":"4","key":"3870_CR74","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.mam.2012.04.005","volume":"33","author":"B Imran","year":"2012","unstructured":"Imran B, Gerard L (2012) Understanding age-related macular degeneration (AMD): relationships between the photoreceptor\/retinal pigment epithelium\/Bruch\u2019s membrane\/choriocapillaris complex. Mol Aspects Med 33(4):295\u2013317. https:\/\/doi.org\/10.1016\/j.mam.2012.04.005","journal-title":"Mol Aspects Med"},{"issue":"2","key":"3870_CR75","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/opo.12675","volume":"40","author":"JH Thomas","year":"2020","unstructured":"Thomas JH, Laura L-M, Carel BH et al (2020) Risk factors for progression of age-related macular degeneration. Ophthalmic Physiol Opt 40(2):140\u2013170. https:\/\/doi.org\/10.1111\/opo.12675","journal-title":"Ophthalmic Physiol Opt"},{"key":"3870_CR76","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.preteyeres.2016.04.003","volume":"54","author":"GL Nathan","year":"2016","unstructured":"Nathan GL, Hanan E, Malkit KS et al (2016) Risk factors and biomarkers of age-related macular degeneration. Prog Retin Eye Res 54:64\u2013102. https:\/\/doi.org\/10.1016\/j.preteyeres.2016.04.003","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"3870_CR77","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/cells1001006","volume":"10","author":"T Annamaria","year":"2021","unstructured":"Annamaria T, Marco F, Maurizio P et al (2021) The impact of oxidative stress on blood\u2013retinal barrier physiology in age-related macular degeneration. Cells 10(1):64. https:\/\/doi.org\/10.3390\/cells1001006","journal-title":"Cells"},{"key":"3870_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2021.01.003","author":"JT Catherine","year":"2021","unstructured":"Catherine JT, Rukhsana GM, Manjot KG (2021) Age-related macular degeneration. Med Clin North Am. https:\/\/doi.org\/10.1016\/j.mcna.2021.01.003","journal-title":"Med Clin North Am"},{"key":"3870_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249752","author":"E Jensen","year":"2020","unstructured":"Jensen E, Jakobsen T, Thiel S et al (2020) Associations between the complement system and choroidal neovascularization in wet age-related macular degeneration. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21249752","journal-title":"Int J Mol Sci"},{"key":"3870_CR80","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.60194","author":"J Malsy","year":"2020","unstructured":"Malsy J, Alvarado A, Lamontagne J et al (2020) Distinct effects of complement and of NLRP3- and non-NLRP3 inflammasomes for choroidal neovascularization. Elife. https:\/\/doi.org\/10.7554\/eLife.60194","journal-title":"Elife"},{"issue":"7","key":"3870_CR81","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1167\/tvst.12.7.17","volume":"12","author":"N Parsons","year":"2023","unstructured":"Parsons N, Annamalai B, Rohrer B (2023) Regulatable complement inhibition of the alternative pathway mitigates wet age-related macular degeneration pathology in a mouse model. Transl Vis Sci Technol 12(7):17. https:\/\/doi.org\/10.1167\/tvst.12.7.17","journal-title":"Transl Vis Sci Technol"},{"key":"3870_CR82","doi-asserted-by":"publisher","first-page":"896274","DOI":"10.3389\/fimmu.2022.896274","volume":"13","author":"T Akter","year":"2022","unstructured":"Akter T, Annamalai B, Obert E et al (2022) Dabigatran and wet AMD, results from retinal pigment epithelial cell monolayers, the mouse model of choroidal neovascularization, and patients from the Medicare data base. Front Immunol 13:896274. https:\/\/doi.org\/10.3389\/fimmu.2022.896274","journal-title":"Front Immunol"},{"key":"3870_CR83","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000455282","volume":"58","author":"S Gis\u00e8le","year":"2017","unstructured":"Gis\u00e8le S (2017) Macular edema of choroidal origin. Dev Ophthalmol 58:202\u2013219. https:\/\/doi.org\/10.1159\/000455282","journal-title":"Dev Ophthalmol"},{"issue":"4","key":"3870_CR84","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.ophtha.2015.11.030","volume":"123","author":"S Neepa","year":"2016","unstructured":"Neepa S, Maureen GM, Daniel FM et al (2016) Angiographic cystoid macular edema and outcomes in the comparison of age-related macular degeneration treatments trials. Ophthalmology 123(4):858\u2013864. https:\/\/doi.org\/10.1016\/j.ophtha.2015.11.030","journal-title":"Ophthalmology"},{"issue":"10","key":"3870_CR85","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/13543776.2019.1671353","volume":"29","author":"TS Claudiu","year":"2019","unstructured":"Claudiu TS (2019) Agents for the prevention and treatment of age-related macular degeneration and macular edema: a literature and patent review. Expert Opin Ther Pat 29(10):761\u2013767. https:\/\/doi.org\/10.1080\/13543776.2019.1671353","journal-title":"Expert Opin Ther Pat"},{"issue":"12","key":"3870_CR86","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.3390\/ijms21124271","volume":"21","author":"YS Daisy","year":"2020","unstructured":"Daisy YS, Erik B, Magali S-G (2020) EMT and EndMT: emerging roles in age-related macular degeneration. Int J Mol Sci 21(12):4271. https:\/\/doi.org\/10.3390\/ijms21124271","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3870_CR87","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.3390\/jcm3041302","volume":"3","author":"RS Janet","year":"2014","unstructured":"Janet RS, Tobias D (2014) Fundus autofluorescence and RPE lipofuscin in age-related macular degeneration. J Clin Med 3(4):1302\u20131321. https:\/\/doi.org\/10.3390\/jcm3041302","journal-title":"J Clin Med"},{"issue":"6","key":"3870_CR88","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1177\/1120672120919337","volume":"30","author":"M Aishwarya","year":"2020","unstructured":"Aishwarya M, Subramanian K, Anuradha S et al (2020) Bruch\u2019s membrane pathology: a mechanistic perspective. Eur J Ophthalmol 30(6):1195\u20131206. https:\/\/doi.org\/10.1177\/1120672120919337","journal-title":"Eur J Ophthalmol"},{"issue":"8","key":"3870_CR89","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1369\/jhc.2009.953448","volume":"57","author":"R Martin","year":"2009","unstructured":"Martin R, Christine AC (2009) Esterified cholesterol is highly localized to Bruch\u2019s membrane, as revealed by lipid histochemistry in wholemounts of human choroid. J Histochem Cytochem 57(8):731\u2013739. https:\/\/doi.org\/10.1369\/jhc.2009.953448","journal-title":"J Histochem Cytochem"},{"issue":"12","key":"3870_CR90","doi-asserted-by":"publisher","first-page":"e0144156","DOI":"10.1371\/journal.pone.0144156","volume":"10","author":"W Yu","year":"2015","unstructured":"Yu W, Ari S, Akiyuki K et al (2015) Correlation of aging and segmental choroidal thickness measurement using swept source optical coherence tomography in healthy eyes. PLoS One 10(12):e0144156. https:\/\/doi.org\/10.1371\/journal.pone.0144156","journal-title":"PLoS One"},{"key":"3870_CR91","doi-asserted-by":"publisher","first-page":"107686","DOI":"10.1016\/j.exer.2019.05.026","volume":"186","author":"S Hannah","year":"2019","unstructured":"Hannah S, Ying S, Bailey HB et al (2019) Increased serum proteins in non-exudative AMD retinas. Exp Eye Res 186:107686. https:\/\/doi.org\/10.1016\/j.exer.2019.05.026","journal-title":"Exp Eye Res"},{"issue":"1","key":"3870_CR92","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.pneurobio.2011.05.011","volume":"95","author":"B Elisa","year":"2011","unstructured":"Elisa B, Antonio P, Raffaele N et al (2011) Age related macular degeneration and drusen: neuroinflammation in the retina. Prog Neurobiol 95(1):14\u201325. https:\/\/doi.org\/10.1016\/j.pneurobio.2011.05.011","journal-title":"Prog Neurobiol"},{"issue":"15","key":"3870_CR93","doi-asserted-by":"publisher","first-page":"e130273","DOI":"10.1172\/jci.insight.130273","volume":"4","author":"H Natalie","year":"2019","unstructured":"Natalie H, Lucia C, Alan H et al (2019) Dysregulated claudin-5 cycling in the inner retina causes retinal pigment epithelial cell atrophy. JCI Insight 4(15):e130273. https:\/\/doi.org\/10.1172\/jci.insight.130273","journal-title":"JCI Insight"},{"issue":"1","key":"3870_CR94","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1038\/s41598-018-21276-2","volume":"8","author":"C Kapil","year":"2018","unstructured":"Kapil C, Wanwisa P, Sudha A et al (2018) Iron overload accelerates the progression of diabetic retinopathy in association with increased retinal renin expression. Sci Rep 8(1):3025. https:\/\/doi.org\/10.1038\/s41598-018-21276-2","journal-title":"Sci Rep"},{"issue":"6865","key":"3870_CR95","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414(6865):813\u2013820. https:\/\/doi.org\/10.1038\/414813a","journal-title":"Nature"},{"key":"3870_CR96","doi-asserted-by":"publisher","DOI":"10.1155\/2007\/43603","author":"AK Renu","year":"2007","unstructured":"Renu AK, Pooi-See C (2007) Oxidative stress and diabetic retinopathy. Exp Diabetes Res. https:\/\/doi.org\/10.1155\/2007\/43603","journal-title":"Exp Diabetes Res"},{"key":"3870_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.visres.2017.06.015","author":"AU Elizabeth","year":"2017","unstructured":"Elizabeth AU, George AU, Finny M et al (2017) Novel therapeutic targets in diabetic macular edema: beyond VEGF. Vision Res. https:\/\/doi.org\/10.1016\/j.visres.2017.06.015","journal-title":"Vision Res"},{"key":"3870_CR98","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1005073","author":"AA David","year":"2012","unstructured":"David AA, Ronald K, Thomas WG (2012) Diabetic retinopathy. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMra1005073","journal-title":"N Engl J Med"},{"key":"3870_CR99","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/801269","author":"S Sher Zaman","year":"2014","unstructured":"Sher Zaman S, Rajes Q, Selva K et al (2014) Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets. Biomed Res Int. https:\/\/doi.org\/10.1155\/2014\/801269","journal-title":"Biomed Res Int"},{"key":"3870_CR100","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-023-05949-w","author":"SH Sandra","year":"2023","unstructured":"Sandra SH, Tim FD, Delaney M et al (2023) Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy. Diabetologia. https:\/\/doi.org\/10.1007\/s00125-023-05949-w","journal-title":"Diabetologia"},{"issue":"10","key":"3870_CR101","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1136\/bjo.2003.038133","volume":"88","author":"RA Kowluru","year":"2004","unstructured":"Kowluru RA, Odenbach S (2004) Role of interleukin-1\u03b2 in the pathogenesis of diabetic retinopathy. Br J Ophthalmol 88(10):1343\u20131347. https:\/\/doi.org\/10.1136\/bjo.2003.038133","journal-title":"Br J Ophthalmol"},{"key":"3870_CR102","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100807RR","author":"L Jianan","year":"2021","unstructured":"Jianan L, Ruotian X, Feng J et al (2021) Tumor necrosis factor ligand-related molecule 1A maintains blood\u2013retinal barrier via modulating SHP-1-Src-VE-cadherin signaling in diabetic retinopathy. FASEB J. https:\/\/doi.org\/10.1096\/fj.202100807RR","journal-title":"FASEB J"},{"issue":"7","key":"3870_CR103","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1002\/jnr.22317","volume":"88","author":"W Shen","year":"2010","unstructured":"Shen W, Li S, Chung SH, Gillies MC (2010) Retinal vascular changes after glial disruption in rats. J Neurosci Res 88(7):1485\u20131499. https:\/\/doi.org\/10.1002\/jnr.22317","journal-title":"J Neurosci Res"},{"issue":"7","key":"3870_CR104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103148","volume":"9","author":"E Shin","year":"2014","unstructured":"Shin E, Huang Q, Gurel Z et al (2014) High glucose alters retinal astrocytes phenotype through increased production of inflammatory cytokines and oxidative stress. PLoS ONE 9(7):e103148. https:\/\/doi.org\/10.1371\/journal.pone.0103148","journal-title":"PLoS ONE"},{"key":"3870_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108796","author":"H Ramos","year":"2023","unstructured":"Ramos H, Hern\u00e1ndez C, Sim\u00f3 R et al (2023) Inflammation: the link between neural and vascular impairment in the diabetic retina and therapeutic implications. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24108796","journal-title":"Int J Mol Sci"},{"issue":"10","key":"3870_CR106","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1136\/bjo.86.10.1139","volume":"86","author":"B Sander","year":"2002","unstructured":"Sander B, Larsen M, Engler C et al (2002) Diabetic macular oedema: the effect of photocoagulation on fluorescein transport across the blood\u2013retinal barrier. Br J Ophthalmol 86(10):1139\u201342. https:\/\/doi.org\/10.1136\/bjo.86.10.1139","journal-title":"Br J Ophthalmol"},{"key":"3870_CR107","doi-asserted-by":"publisher","first-page":"8458472","DOI":"10.1155\/2019\/8458472","volume":"2019","author":"N Mahajan","year":"2019","unstructured":"Mahajan N, Arora P, Sandhir R (2019) Perturbed biochemical pathways and associated oxidative stress lead to vascular dysfunctions in diabetic retinopathy. Oxid Med Cell Longev 2019:8458472. https:\/\/doi.org\/10.1155\/2019\/8458472","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"3870_CR108","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1089\/ars.2011.3906","volume":"15","author":"T Frey","year":"2011","unstructured":"Frey T, Antonetti D (2011) Alterations to the blood-retinal barrier in diabetes: cytokines and reactive oxygen species. Antioxid Redox Signal 15(5):1271\u20131284. https:\/\/doi.org\/10.1089\/ars.2011.3906","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"3870_CR109","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1167\/iovs.10-6518","volume":"52","author":"H Xu","year":"2011","unstructured":"Xu H, Le Y (2011) Significance of outer blood-retina barrier breakdown in diabetes and ischemia. Invest Ophthalmol Vis Sci 52(5):2160\u20132164. https:\/\/doi.org\/10.1167\/iovs.10-6518","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"3870_CR110","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.ajpath.2017.01.014","volume":"187","author":"A Imai","year":"2017","unstructured":"Imai A, Toriyama Y, Iesato Y et al (2017) Adrenomedullin suppresses vascular endothelial growth factor-induced vascular hyperpermeability and inflammation in retinopathy. Am J Pathol 187(5):999\u20131015. https:\/\/doi.org\/10.1016\/j.ajpath.2017.01.014","journal-title":"Am J Pathol"},{"key":"3870_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/cells11050779","author":"Z Yan","year":"2022","unstructured":"Yan Z, Wang C, Meng Z et al (2022) C1q\/TNF-related protein 3 prevents diabetic retinopathy via AMPK-dependent stabilization of blood-retinal barrier tight junctions. Cells. https:\/\/doi.org\/10.3390\/cells11050779","journal-title":"Cells"},{"issue":"3","key":"3870_CR112","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1167\/iovs.10-5768","volume":"52","author":"H Huang","year":"2011","unstructured":"Huang H, Gandhi J, Zhong X et al (2011) TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis. Invest Ophthalmol Vis Sci 52(3):1336\u20131344. https:\/\/doi.org\/10.1167\/iovs.10-5768","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"3870_CR113","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1167\/tvst.8.5.32","volume":"8","author":"M Mesquida","year":"2019","unstructured":"Mesquida M, Drawnel F, Lait P et al (2019) Modelling macular edema: the effect of IL-6 and IL-6R blockade on human blood\u2013retinal barrier integrity in vitro. Transl Vis Sci Technol 8(5):32. https:\/\/doi.org\/10.1167\/tvst.8.5.32","journal-title":"Transl Vis Sci Technol"},{"key":"3870_CR114","doi-asserted-by":"publisher","first-page":"564077","DOI":"10.3389\/fimmu.2020.564077","volume":"11","author":"U Kinuthia","year":"2020","unstructured":"Kinuthia U, Wolf A, Langmann T (2020) Microglia and inflammatory responses in diabetic retinopathy. Front Immunol 11:564077. https:\/\/doi.org\/10.3389\/fimmu.2020.564077","journal-title":"Front Immunol"},{"key":"3870_CR115","doi-asserted-by":"publisher","first-page":"1270145","DOI":"10.3389\/fendo.2023.1270145","volume":"14","author":"W Sun","year":"2023","unstructured":"Sun W, An X, Zhang Y et al (2023) The ideal treatment timing for diabetic retinopathy: the molecular pathological mechanisms underlying early-stage diabetic retinopathy are a matter of concern. Front Endocrinol 14:1270145. https:\/\/doi.org\/10.3389\/fendo.2023.1270145","journal-title":"Front Endocrinol"},{"key":"3870_CR116","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.bcp.2019.07.010","volume":"168","author":"C Platania","year":"2019","unstructured":"Platania C, Lazzara F, Fidilio A et al (2019) Blood-retinal barrier protection against high glucose damage: the role of P2X7 receptor. Biochem Pharmacol 168:249\u2013258. https:\/\/doi.org\/10.1016\/j.bcp.2019.07.010","journal-title":"Biochem Pharmacol"},{"key":"3870_CR117","doi-asserted-by":"publisher","first-page":"15296","DOI":"10.1038\/ncomms15296","volume":"8","author":"D Park","year":"2017","unstructured":"Park D, Lee J, Kim J et al (2017) Plastic roles of pericytes in the blood\u2013retinal barrier. Nat Commun 8:15296. https:\/\/doi.org\/10.1038\/ncomms15296","journal-title":"Nat Commun"},{"issue":"1","key":"3870_CR118","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2337\/db10-0454","volume":"60","author":"H Hammes","year":"2011","unstructured":"Hammes H, Feng Y, Pfister F et al (2011) Diabetic retinopathy: targeting vasoregression. Diabetes 60(1):9\u201316. https:\/\/doi.org\/10.2337\/db10-0454","journal-title":"Diabetes"},{"issue":"10","key":"3870_CR119","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1167\/iovs.17-21510","volume":"58","author":"B Haj Najeeb","year":"2017","unstructured":"Haj Najeeb B, Simader C, Deak G et al (2017) The distribution of leakage on fluorescein angiography in diabetic macular edema: a new approach to its etiology. Invest Ophthalmol Vis Sci 58(10):3986\u20133990. https:\/\/doi.org\/10.1167\/iovs.17-21510","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"3870_CR120","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3390\/antiox11040617","volume":"11","author":"R Carpi-Santos","year":"2022","unstructured":"Carpi-Santos R, de Melo Reis RA, Gomes FCA, Calaza KC (2022) Contribution of M\u00fcller cells in the diabetic retinopathy development: focus on oxidative stress and inflammation. Antioxidants 11(4):617. https:\/\/doi.org\/10.3390\/antiox11040617","journal-title":"Antioxidants"},{"issue":"6","key":"3870_CR121","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00592-017-0984-z","volume":"54","author":"A Arroba","year":"2017","unstructured":"Arroba A, Valverde \u00c1 (2017) Modulation of microglia in the retina: new insights into diabetic retinopathy. Acta Diabetol 54(6):527\u2013533. https:\/\/doi.org\/10.1007\/s00592-017-0984-z","journal-title":"Acta Diabetol"},{"key":"3870_CR122","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.visres.2017.02.006","volume":"139","author":"T Xia","year":"2017","unstructured":"Xia T, Rizzolo L (2017) Effects of diabetic retinopathy on the barrier functions of the retinal pigment epithelium. Vis Res 139:72\u201381. https:\/\/doi.org\/10.1016\/j.visres.2017.02.006","journal-title":"Vis Res"},{"key":"3870_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19041056","author":"F Willermain","year":"2018","unstructured":"Willermain F, Scifo L, Weber C et al (2018) Potential interplay between hyperosmolarity and inflammation on retinal pigmented epithelium in pathogenesis of diabetic retinopathy. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19041056","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3870_CR124","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00125-020-05299-x","volume":"64","author":"H Xie","year":"2021","unstructured":"Xie H, Zhang C, Liu D et al (2021) Erythropoietin protects the inner blood-retinal barrier by inhibiting microglia phagocytosis via Src\/Akt\/cofilin signalling in experimental diabetic retinopathy. Diabetologia 64(1):211\u2013225. https:\/\/doi.org\/10.1007\/s00125-020-05299-x","journal-title":"Diabetologia"},{"key":"3870_CR125","doi-asserted-by":"publisher","first-page":"831660","DOI":"10.3389\/fimmu.2022.831660","volume":"13","author":"L Tang","year":"2022","unstructured":"Tang L, Zhang C, Lu L et al (2022) Melatonin maintains inner blood\u2013retinal barrier by regulating microglia via inhibition of PI3K\/Akt\/Stat3\/NF-\u03baB signaling pathways in experimental diabetic retinopathy. Front Immunol 13:831660. https:\/\/doi.org\/10.3389\/fimmu.2022.831660","journal-title":"Front Immunol"},{"issue":"5","key":"3870_CR126","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/labinvest.3700251","volume":"85","author":"S Giebel","year":"2005","unstructured":"Giebel S, Menicucci G, McGuire P et al (2005) Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Lab Invest 85(5):597\u2013607. https:\/\/doi.org\/10.1038\/labinvest.3700251","journal-title":"Lab Invest"},{"issue":"10","key":"3870_CR127","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1136\/bjo.86.10.1139","volume":"86","author":"B Sander","year":"2002","unstructured":"Sander B, Larsen M, Engler C, Moldow B, Lund-Andersen H (2002) Diabetic macular oedema: the effect of photocoagulation on fluorescein transport across the blood\u2013retinal barrier. Br J Ophthalmol 86(10):1139\u20131142. https:\/\/doi.org\/10.1136\/bjo.86.10.1139","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"3870_CR128","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/112067219800800301","volume":"8","author":"J Cunha-Vaz","year":"1998","unstructured":"Cunha-Vaz J (1998) Diabetic macular edema. Eur J Ophthalmol 8(3):127\u2013130. https:\/\/doi.org\/10.1177\/112067219800800301","journal-title":"Eur J Ophthalmol"},{"key":"3870_CR129","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.visres.2017.06.015","volume":"139","author":"E Urias","year":"2017","unstructured":"Urias E, Urias G, Monickaraj F et al (2017) Novel therapeutic targets in diabetic macular edema: beyond VEGF. Vis Res 139:221\u2013227. https:\/\/doi.org\/10.1016\/j.visres.2017.06.015","journal-title":"Vis Res"},{"issue":"6","key":"3870_CR130","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4239\/wjd.v2.i6.98","volume":"2","author":"P Romero-Aroca","year":"2011","unstructured":"Romero-Aroca P (2011) Managing diabetic macular edema: the leading cause of diabetes blindness. World J Diabetes 2(6):98\u2013104. https:\/\/doi.org\/10.4239\/wjd.v2.i6.98","journal-title":"World J Diabetes"},{"issue":"11","key":"3870_CR131","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.2337\/dc10-1580","volume":"33","author":"P Romero-Aroca","year":"2010","unstructured":"Romero-Aroca P (2010) Targeting the pathophysiology of diabetic macular edema. Diabetes Care 33(11):2484\u20132485. https:\/\/doi.org\/10.2337\/dc10-1580","journal-title":"Diabetes Care"},{"key":"3870_CR132","doi-asserted-by":"publisher","first-page":"5185128","DOI":"10.1155\/2019\/5185128","volume":"2019","author":"H Noma","year":"2019","unstructured":"Noma H, Yasuda K, Shimura M (2019) Cytokines and the pathogenesis of macular edema in branch retinal vein occlusion. J Ophthalmol 2019:5185128. https:\/\/doi.org\/10.1155\/2019\/5185128","journal-title":"J Ophthalmol"},{"issue":"16","key":"3870_CR133","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1523\/jneurosci.5368-06.2007","volume":"27","author":"Y Choi","year":"2007","unstructured":"Choi Y, Kim J, Kim W et al (2007) AKAP12 regulates human blood\u2013retinal barrier formation by downregulation of hypoxia-inducible factor-1alpha. J Neurosci Official J Soc Neurosci 27(16):4472\u201381. https:\/\/doi.org\/10.1523\/jneurosci.5368-06.2007","journal-title":"J Neurosci Official J Soc Neurosci"},{"issue":"38","key":"3870_CR134","doi-asserted-by":"publisher","first-page":"e22267","DOI":"10.1097\/md.0000000000022267","volume":"99","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Duan J, Chang T, Li X, Wang M, Zhang M (2020) Comparative efficacy of intravitreal pharmacotherapy for macular edema secondary to retinal vein occlusion: a protocol for the systematic review and network meta-analysis. Medicine 99(38):e22267. https:\/\/doi.org\/10.1097\/md.0000000000022267","journal-title":"Medicine"},{"issue":"8","key":"3870_CR135","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.drudis.2019.05.034","volume":"24","author":"F Behar-Cohen","year":"2019","unstructured":"Behar-Cohen F, Dernigoghossian M, Andrieu-Soler C, Levy R, Cohen R, Zhao M (2019) Potential antiedematous effects of intravitreous anti-VEGF, unrelated to VEGF neutralization. Drug Discov Today 24(8):1436\u20131439. https:\/\/doi.org\/10.1016\/j.drudis.2019.05.034","journal-title":"Drug Discov Today"},{"issue":"6","key":"3870_CR136","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3390\/brainsci10060330","volume":"10","author":"JS Pe\u00f1a","year":"2020","unstructured":"Pe\u00f1a JS, Vazquez M (2020) VEGF upregulates EGFR expression to stimulate chemotactic behaviors in the rMC-1 model of M\u00fcller Glia. Brain Sci 10(6):330. https:\/\/doi.org\/10.3390\/brainsci10060330","journal-title":"Brain Sci"},{"key":"3870_CR137","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.exer.2015.05.010","volume":"136","author":"A Trost","year":"2015","unstructured":"Trost A, Motloch K, Bruckner D et al (2015) Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension. Exp Eye Res 136:59\u201371. https:\/\/doi.org\/10.1016\/j.exer.2015.05.010","journal-title":"Exp Eye Res"},{"issue":"2","key":"3870_CR138","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00441-013-1672-0","volume":"353","author":"E Tamm","year":"2013","unstructured":"Tamm E, Grehn F, Pfeiffer N (2013) Neuroprotection in glaucoma. Cell Tissue Res 353(2):201\u2013203. https:\/\/doi.org\/10.1007\/s00441-013-1672-0","journal-title":"Cell Tissue Res"},{"issue":"1","key":"3870_CR139","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41418-022-01046-4","volume":"30","author":"F Yao","year":"2023","unstructured":"Yao F, Peng J, Zhang E et al (2023) Pathologically high intraocular pressure disturbs normal iron homeostasis and leads to retinal ganglion cell ferroptosis in glaucoma. Cell Death Differ 30(1):69\u201381. https:\/\/doi.org\/10.1038\/s41418-022-01046-4","journal-title":"Cell Death Differ"},{"key":"3870_CR140","doi-asserted-by":"publisher","first-page":"101217","DOI":"10.1016\/j.preteyeres.2023.101217","volume":"97","author":"L Alarcon-Martinez","year":"2023","unstructured":"Alarcon-Martinez L, Shiga Y, Villafranca-Baughman D, Vargas JLC, Paredes IAV, Quintero H, Di Polo A (2023) Neurovascular dysfunction in glaucoma. Prog Retinal Eye Res 97:101217. https:\/\/doi.org\/10.1016\/j.preteyeres.2023.101217","journal-title":"Prog Retinal Eye Res"},{"key":"3870_CR141","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1463-5224.2007.00585.x","volume":"10","author":"BG Mangan","year":"2007","unstructured":"Mangan BG, Al-Yahya K, Chen CT, Gionfriddo JR, Powell CC, Dubielzig RR, Madl JE (2007) Retinal pigment epithelial damage, breakdown of the blood\u2013retinal barrier, and retinal inflammation in dogs with primary glaucoma. Vet Ophthalmol 10:117\u2013124. https:\/\/doi.org\/10.1111\/j.1463-5224.2007.00585.x","journal-title":"Vet Ophthalmol"},{"key":"3870_CR142","doi-asserted-by":"publisher","first-page":"1354569","DOI":"10.3389\/fncel.2024.1354569","volume":"18","author":"J Fern\u00e1ndez-Albarral","year":"2024","unstructured":"Fern\u00e1ndez-Albarral J, Ram\u00edrez A, de Hoz R et al (2024) Glaucoma: from pathogenic mechanisms to retinal glial cell response to damage. Front Cell Neurosci 18:1354569. https:\/\/doi.org\/10.3389\/fncel.2024.1354569","journal-title":"Front Cell Neurosci"},{"issue":"7","key":"3870_CR143","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/labinvest.2014.72","volume":"94","author":"S Tan","year":"2014","unstructured":"Tan S, Duan H, Xun T et al (2014) HIV-1 impairs human retinal pigment epithelial barrier function: possible association with the pathogenesis of HIV-associated retinopathy. Lab Invest 94(7):777\u2013787. https:\/\/doi.org\/10.1038\/labinvest.2014.72","journal-title":"Lab Invest"},{"key":"3870_CR144","doi-asserted-by":"publisher","first-page":"102350","DOI":"10.1016\/j.pneurobio.2022.102350","volume":"219","author":"H Xu","year":"2022","unstructured":"Xu H, Chen M (2022) Immune response in retinal degenerative diseases\u2014Time to rethink? Prog Neurobiol 219:102350. https:\/\/doi.org\/10.1016\/j.pneurobio.2022.102350","journal-title":"Prog Neurobiol"},{"issue":"12","key":"3870_CR145","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1479","volume":"12","author":"L Ferreira","year":"2023","unstructured":"Ferreira L, Williams K, Best G et al (2023) Inflammatory cytokines as mediators of retinal endothelial barrier dysfunction in non-infectious uveitis. Clin Transl Immunol 12(12):e1479. https:\/\/doi.org\/10.1002\/cti2.1479","journal-title":"Clin Transl Immunol"},{"key":"3870_CR146","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.mvr.2013.06.007","volume":"89","author":"T Palenski","year":"2013","unstructured":"Palenski T, Sorenson C, Sheibani N (2013) Inflammatory cytokine-specific alterations in retinal endothelial cell function. Microvasc Res 89:57\u201369. https:\/\/doi.org\/10.1016\/j.mvr.2013.06.007","journal-title":"Microvasc Res"},{"key":"3870_CR147","doi-asserted-by":"publisher","first-page":"156407","DOI":"10.1016\/j.cyto.2023.156407","volume":"173","author":"L Barros Ferreira","year":"2024","unstructured":"Barros Ferreira L, Ashander L, Ma Y et al (2024) Effects of tumor necrosis factor-\u03b1 and interleukin-1\u03b2 on human retinal endothelial cells. Cytokine 173:156407. https:\/\/doi.org\/10.1016\/j.cyto.2023.156407","journal-title":"Cytokine"},{"issue":"2","key":"3870_CR148","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/09273948.2019.1576910","volume":"27","author":"M Accorinti","year":"2019","unstructured":"Accorinti M, Okada AA, Smith JR, Gilardi M (2019) Epidemiology of macular edema in uveitis. Ocul Immunol Inflam 27(2):169\u2013180. https:\/\/doi.org\/10.1080\/09273948.2019.1576910","journal-title":"Ocul Immunol Inflam"},{"issue":"5","key":"3870_CR149","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.3390\/ijms24054676","volume":"24","author":"JY Yang","year":"2023","unstructured":"Yang JY, Goldberg D, Sobrin L (2023) Interleukin-6 and macular edema: a review of outcomes with inhibition. Int J Mol Sci 24(5):4676. https:\/\/doi.org\/10.3390\/ijms24054676","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3870_CR150","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ophtha.2008.09.034","volume":"116","author":"H Noma","year":"2009","unstructured":"Noma H, Funatsu H, Mimura T et al (2009) Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Ophthalmology 116(1):87\u201393. https:\/\/doi.org\/10.1016\/j.ophtha.2008.09.034","journal-title":"Ophthalmology"},{"key":"3870_CR151","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.2147\/ott.s228532","volume":"13","author":"H Wang","year":"2020","unstructured":"Wang H, Yang J, Pan H et al (2020) Dinutuximab synergistically enhances the cytotoxicity of natural killer cells to retinoblastoma through the perforin-granzyme B pathway. OncoTargets Ther 13:3903\u20133920. https:\/\/doi.org\/10.2147\/ott.s228532","journal-title":"OncoTargets Ther"},{"issue":"4","key":"3870_CR152","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000336906","volume":"227","author":"S Ghorbanian","year":"2012","unstructured":"Ghorbanian S, Jaulim A, Chatziralli I (2012) Diagnosis and treatment of Coats\u2019 disease: a review of the literature. Ophthalmologica 227(4):175\u2013182. https:\/\/doi.org\/10.1159\/000336906","journal-title":"Ophthalmologica"},{"key":"3870_CR153","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051636","author":"C Fresta","year":"2020","unstructured":"Fresta C, Fidilio A, Caruso G et al (2020) A new human blood\u2013retinal barrier model based on endothelial cells, pericytes, and astrocytes. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21051636","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3870_CR154","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1038\/s41467-024-45456-z","volume":"15","author":"T Maurissen","year":"2024","unstructured":"Maurissen T, Spielmann A, Schellenberg G et al (2024) Modeling early pathophysiological phenotypes of diabetic retinopathy in a human inner blood\u2013retinal barrier-on-a-chip. Nat Commun 15(1):1372. https:\/\/doi.org\/10.1038\/s41467-024-45456-z","journal-title":"Nat Commun"},{"key":"3870_CR155","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ejpb.2023.01.026","volume":"184","author":"L Hellinen","year":"2023","unstructured":"Hellinen L, Hongisto H, Ramsay E et al (2023) Comparison of barrier properties of outer blood\u2013retinal barrier models\u2014human stem cell-based models as a novel tool for ocular drug discovery. Eur J Pharm Biopharm 184:181\u2013188. https:\/\/doi.org\/10.1016\/j.ejpb.2023.01.026","journal-title":"Eur J Pharm Biopharm"},{"issue":"20","key":"3870_CR156","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.3390\/cells12202443","volume":"12","author":"K Bora","year":"2023","unstructured":"Bora K, Kushwah N, Maurya M, Pavlovich MC, Wang Z, Chen J (2023) Assessment of inner blood\u2013retinal barrier: animal models and methods. Cells 12(20):2443. https:\/\/doi.org\/10.3390\/cells12202443","journal-title":"Cells"},{"issue":"8","key":"3870_CR157","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3390\/biom10081119","volume":"10","author":"A Tawfik","year":"2020","unstructured":"Tawfik A, Samra YA, Elsherbiny NM, Al-Shabrawey M (2020) Implication of hyperhomocysteinemia in blood retinal barrier (BRB) dysfunction. Biomolecules 10(8):1119. https:\/\/doi.org\/10.3390\/biom10081119","journal-title":"Biomolecules"},{"issue":"21","key":"3870_CR158","doi-asserted-by":"publisher","first-page":"11876","DOI":"10.3390\/ijms222111876","volume":"2","author":"EM Byrne","year":"2021","unstructured":"Byrne EM, Llori\u00e1n-Salvador M, Lyons TJ, Chen M, Xu H (2021) Tofacitinib ameliorates retinal vascular leakage in a murine model of diabetic retinopathy with type 2 diabetes. Int J Mol Sci 2(21):11876. https:\/\/doi.org\/10.3390\/ijms222111876","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3870_CR159","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1167\/iovs.10-5768","volume":"52","author":"H Huang","year":"2011","unstructured":"Huang H, Gandhi JK, Zhong X, Wei Y, Gong J, Duh EJ, Vinores SA (2011) TNF\u03b1 is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis. Invest Ophthalmol Vis Sci 52(3):1336\u20131344. https:\/\/doi.org\/10.1167\/iovs.10-5768","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3870_CR160","doi-asserted-by":"publisher","first-page":"149253","DOI":"10.1016\/j.brainres.2024.149253","volume":"1846","author":"X Xu","year":"2025","unstructured":"Xu X, Xu S, Gao Y, He S, He J, Chen X, Zhang X (2025) Remote ischemic conditioning slows blood\u2013retinal barrier damage in type 1 diabetic rats. Brain Res 1846:149253. https:\/\/doi.org\/10.1016\/j.brainres.2024.149253","journal-title":"Brain Res"},{"issue":"3","key":"3870_CR161","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1167\/iovs.15-18658","volume":"57","author":"L Fan","year":"2016","unstructured":"Fan L, Yan H (2016) FTY720 attenuates retinal inflammation and protects blood\u2013retinal barrier in diabetic rats. Invest Ophthalmol Vis Sci 57(3):1254\u20131263. https:\/\/doi.org\/10.1167\/iovs.15-18658","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"3870_CR162","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1167\/iovs.08-1754","volume":"49","author":"M Al-Shabrawey","year":"2008","unstructured":"Al-Shabrawey M, Bartoli M, El-Remessy AB, Ma G, Matragoon S, Lemtalsi T, Caldwell RB (2008) Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy. Invest Ophthalmol Vis Sci 49(7):3231\u20133238. https:\/\/doi.org\/10.1167\/iovs.08-1754","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"3870_CR163","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/s0002-9440(10)63728-5","volume":"164","author":"S Miyahara","year":"2004","unstructured":"Miyahara S, Kiryu J, Yamashiro K et al (2004) Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes. Am J Pathol 164(5):1697\u20131706. https:\/\/doi.org\/10.1016\/s0002-9440(10)63728-5","journal-title":"Am J Pathol"},{"issue":"4","key":"3870_CR164","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1167\/iovs.04-0905","volume":"46","author":"H Tamura","year":"2005","unstructured":"Tamura H, Miyamoto K, Kiryu J et al (2005) Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Invest Ophthalmol Vis Sci 46(4):1440\u20131444. https:\/\/doi.org\/10.1167\/iovs.04-0905","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3870_CR165","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.2147\/opth.s79948","volume":"9","author":"P Dugel","year":"2015","unstructured":"Dugel P, Bandello F, Loewenstein A (2015) Dexamethasone intravitreal implant in the treatment of diabetic macular edema. Clin Ophthalmol (Auckland, NZ) 9:1321\u20131335. https:\/\/doi.org\/10.2147\/opth.s79948","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"4","key":"3870_CR166","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.2337\/db07-0982","volume":"57","author":"X Zhang","year":"2008","unstructured":"Zhang X, Bao S, Lai D et al (2008) Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas. Diabetes 57(4):1026\u20131033. https:\/\/doi.org\/10.2337\/db07-0982","journal-title":"Diabetes"},{"issue":"1","key":"3870_CR167","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1038\/s41467-019-10219-8","volume":"10","author":"G Weiner","year":"2019","unstructured":"Weiner G, Shah S, Angelopoulos C et al (2019) Cholinergic neural activity directs retinal layer-specific angiogenesis and blood retinal barrier formation. Nat Commun 10(1):2477. https:\/\/doi.org\/10.1038\/s41467-019-10219-8","journal-title":"Nat Commun"},{"issue":"9","key":"3870_CR168","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1167\/tvst.11.9.19","volume":"11","author":"H Nguyen","year":"2022","unstructured":"Nguyen H, Chen H, Vuppalapaty M et al (2022) SZN-413, a FZD4 agonist, as a potential novel therapeutic for the treatment of diabetic retinopathy. Transl Vis Sci Technol 11(9):19. https:\/\/doi.org\/10.1167\/tvst.11.9.19","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"3870_CR169","doi-asserted-by":"publisher","first-page":"100586","DOI":"10.1016\/j.xops.2024.100586","volume":"5","author":"M Barakat","year":"2025","unstructured":"Barakat M, Brown D, Hu A et al (2025) Safety and tolerability of suprachoroidal axitinib injectable suspension, for neovascular age-related macular degeneration; phase I\/IIa open-label, dose-escalation trial. Ophthalmol Sci 5(1):100586. https:\/\/doi.org\/10.1016\/j.xops.2024.100586","journal-title":"Ophthalmol Sci"},{"issue":"2","key":"3870_CR170","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41591-024-02802-4","volume":"30","author":"S Crespo-Garcia","year":"2024","unstructured":"Crespo-Garcia S, Fournier F, Diaz-Marin R et al (2024) Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical and phase 1 trial results. Nat Med 30(2):443\u2013454. https:\/\/doi.org\/10.1038\/s41591-024-02802-4","journal-title":"Nat Med"},{"issue":"32","key":"3870_CR171","doi-asserted-by":"publisher","first-page":"2402368","DOI":"10.1002\/advs.202402368","volume":"11","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Zhao C, Shi Z, Heger Z, Jing H, Shi Z, Li N (2024) A glucose-responsive hydrogel inhibits primary and secondary BRB injury for retinal microenvironment remodeling in diabetic retinopathy. Adv Sci 11(32):2402368. https:\/\/doi.org\/10.1002\/advs.202402368","journal-title":"Adv Sci"},{"issue":"8","key":"3870_CR172","doi-asserted-by":"publisher","first-page":"5550","DOI":"10.1167\/iovs.13-12144","volume":"54","author":"S Tari","year":"2013","unstructured":"Tari S, Youssif M, Samson C et al (2013) Polychromatic angiography for the assessment of VEGF-induced BRB dysfunction in the rabbit retina. Invest Ophthalmol Vis Sci 54(8):5550\u20135558. https:\/\/doi.org\/10.1167\/iovs.13-12144","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"3870_CR173","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1167\/iovs.14-16144","volume":"56","author":"A Abu El-Asrar","year":"2015","unstructured":"Abu El-Asrar A, Mohammad G, Nawaz M et al (2015) The chemokine platelet factor-4 variant (PF-4var)\/CXCL4L1 inhibits diabetes-induced blood-retinal barrier breakdown. Invest Ophthalmol Vis Sci 56(3):1956\u20131964. https:\/\/doi.org\/10.1167\/iovs.14-16144","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"3870_CR174","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1080\/14712598.2021.1830969","volume":"20","author":"D Ng","year":"2020","unstructured":"Ng D, Fung N, Yip F et al (2020) Ranibizumab for myopic choroidal neovascularization. Expert Opin Biol Ther 20(12):1385\u20131393. https:\/\/doi.org\/10.1080\/14712598.2021.1830969","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"3870_CR175","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1038\/s41598-019-38504-y","volume":"9","author":"B Jung","year":"2019","unstructured":"Jung B, Kim J, Lee J et al (2019) Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy. Sci Rep 9(1):2055. https:\/\/doi.org\/10.1038\/s41598-019-38504-y","journal-title":"Sci Rep"},{"issue":"4","key":"3870_CR176","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.oret.2023.10.018","volume":"8","author":"S Pandit","year":"2024","unstructured":"Pandit S, Momenaei B, Wakabayashi T et al (2024) Clinical outcomes of faricimab in patients with previously treated neovascular age-related macular degeneration. Ophthalmol Retina 8(4):360\u2013366. https:\/\/doi.org\/10.1016\/j.oret.2023.10.018","journal-title":"Ophthalmol Retina"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03870-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-025-03870-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03870-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T17:03:33Z","timestamp":1764954213000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-025-03870-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":176,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3870"],"URL":"https:\/\/doi.org\/10.1007\/s10792-025-03870-2","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"10"}}